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Background: Prophylaxis to prevent relapses in the central nervous system after childhood acute lymphoblastic
leukemia (ALL) used to consist of both intrathecal chemotherapy (CT) and cranial irradiation (CRT). CRT was mostly
abolished in the eighties because of its neurotoxicity, and replaced with more intensive intrathecal CT. In this study,
a group of survivors treated with CRT before 1983 and another group treated without CRT thereafter are
investigated 20–25 years later, giving a much stronger perspective on long-term quality of life than previous
studies. The outcomes will help to better understand these groups’ current needs and will aid in anticipating late
effects of prophylactic CRT that is currently applied for other diseases. This study evaluates oscillatory neuronal
activity in these long-term survivors. Power spectrum deviations are hypothesized to correlate with cognitive
dysfunction.
Methods: Resting state eyes-closed magnetoencephalography (MEG) recordings were obtained from 14 ALL
survivors treated with CT + CRT, 18 treated with CT alone and 35 controls. Relative spectral power was calculated in
the δ, θ, α1, α2, β and γ frequency bands. The Amsterdam Neuropsychological Tasks (ANT) program was used to
assess cognition in the executive functions domain. MEG data and ANT scores were correlated.
Results: In the CT + CRT group, relative θ power was slightly increased (p = 0.069) and α2 power was significantly
decreased (p = 0.006). The CT + CRT group performed worse on various cognitive tests. A deficiency in visuomotor
accuracy, especially of the right hand, could be clearly associated with the deviating regional θ and α2 powers
(0.471 < r < 0.697). A significant association between decreased regional α2 power and less attentional fluctuations
was found for CT + CRT patients as well as controls (0.078 < r < 0.666). Patients treated with CT alone displayed a
power spectrum similar to controls, except for a significantly increased level of left frontal α2 power (p = 0.030).
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Conclusions: The tendency towards global slowing of brain oscillatory activity, together with the fact that
dementia has been reported as a late effect of CRT and the neuropsychological deficiencies currently present,
suggest that the irradiated brain might be aging faster and could be at risk for early-onset dementia. The CT group
showed no signs of early aging.
Keywords: Late effects, Childhood cancer, Magnetoencephalography, Resting state, Oscillatory power,
Neuropsychology, Accelerated agingBackground
Acute lymphoblastic leukemia (ALL) is the most com-
mon malignancy diagnosed in children, representing al-
most one third of all childhood cancers. There is a peak
incidence at 2–5 years of age. Over the last decades, cure
rates for ALL patients have gone from less than 5% to
over 80% due to improved treatment protocols [1]. An
essential part of ALL treatment is central nervous system
(CNS) prophylaxis, mostly performed by cranial irradi-
ation (CRT) and/or intrathecal chemotherapy (CT). In
the Netherlands, CRT was abolished in 1983 [2].
As survival rates for ALL continue to rise, the focus of
clinicians is increasingly shifting to the late effects of
therapy and related quality of life [3]. CRT patients have
a 13.6 times higher chance of developing secondary neo-
plasms in the irradiated field within 20 years following
treatment [4]. Late neurotoxic effects of CRT are also
well described. Many studies have reported a causative
link between prophylactic CRT and long-term neurocog-
nitive deficits among ALL survivors, for example mem-
ory problems, cognitive slowing and attention deficits
[5-8]. Cognitive effects beyond 10 years after treatment
are largely unknown [9]. This study provides data from
patients, on average 25 years post childhood treatment,
giving a much stronger perspective on long-term quality
of life than previous studies. These outcomes not only
help to better understand these groups’ current needs,
but can also aid in anticipating late effects of currently
applied prophylactic CRT that is still part of treatment
for ALL in some countries, but also for brain tumours
and small cell lung cancer.
Neurocognitive late effects of chemotherapy alone are
relatively subtle compared to the effects of CRT. How-
ever, a significant percentage of children that received
chemotherapy alone also suffer from neurocognitive def-
icits, particularly in the domain of executive functioning
(EF) [10-13]. The underlying mechanisms of neurotox-
icity, caused by either CRT or CT, are not yet fully
understood. Structural imaging has revealed smaller
white matter volumes in this population, which corre-
lated with cognitive dysfunction [9]. Functional neuroi-
maging methods like functional magnetic resonance
imaging (fMRI), electroencephalography (EEG) or mag-
netoencephalography (MEG) have rarely been applied inlate effect studies of cancer treatment, while these meth-
ods are very suitable to study subtle brain dysfunction.
Among the available functional imaging techniques,
MEG has the unique property of combining high tem-
poral resolution with good spatial resolution. The MEG
signal is quantified in spectral power, which indicates
the strength of magnetic induction fields generated by
oscillatory neuronal activity and is decomposed into fre-
quency bands [14]. Relative power is the percentage of
power in any band compared with the sum of the power
of all frequency bands. A power spectrum that displays a
shift towards relatively more power in the lower fre-
quency bands is generally considered to be a patho-
logical sign of slowing brain activity and is associated
with deteriorated cognition [15,16]. Also, increased δ or
θ power is known as a nonspecific sign of brain path-
ology [17]. In this paper we will describe relative spectral
power changes assessed by MEG during resting state
with eyes closed. To our knowledge, this is the first
study to use MEG in this population. We hypothesize
that the pattern of oscillatory activity will deviate from
that of controls and that the deviations will correlate
with cognitive dysfunction.
In 1989, Tucker et al. conducted a study of long-term
neurocognitive effects (11.5 ± 7 years after treatment) of
CT+CRT in ALL and Non Hodgkin Lymphoma (NHL)
survivors treated at age 15–69 [18]. They compared the
effects between a group treated at 25 years of age or
younger and a group treated at an older age. In the
younger group, abnormalities were more outspoken, indi-
cating higher susceptibility to neurotoxicity at a younger
age. Using EEG, they found excess θ activity and slightly
slowed α. The abnormalities were interpreted as minor,
but relatively more severe in the younger group, reflect-
ing subtle cerebral cortical dysfunction. Therefore, an
association between worse outcome and younger age at
treatment is hypothesized.
Methods
Subjects
Seventy-five eligible ALL survivors were identified from
patient records of the VU University Medical Center
(VUMC) and the Academic Medical Center (AMC)
Amsterdam. They were sent a letter explaining the study
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nately, 45% were unwilling to participate or met one or
more of the exclusion criteria (i.e. use of centrally acting
drugs, active psychiatric disease or symptoms, pre-
existing CNS disorders, metal parts in the body or preg-
nancy). Survivors who were willing to participate were
requested to recruit a control (sibling, partner or friend,
n = 44). The ALL survivors were treated according to
two different protocols developed by the Dutch Child-
hood Leukemia Study Group (DCLSG). The first group,
CT+CRT (n = 18) was treated according to DCLSG
protocol ALL-5 (1979–1984), which consisted of stand-
ard dose CT (intravenously administered vincristine,
prednisone, L-asparaginase, daunorubicine, intrathecal
injections of methotrexate (MTX) and prednisolone)
and CRT (2500 Gy). The second group, CT (n = 23), was
treated according to DCLSG protocol ALL-6 (1984–
1988), which consisted of standard dose CT (intravenous
vincristine, dexamethasone, L-asparaginase, intrathecal
MTX and prednisolone), without CRT. Duration of
treatment was approximately 2 years.
Two CT+CRT patients were excluded from data ana-
lysis because meningiomas were discovered during as-
sessment. Additionally, data from two CT+CRT patients,
five CT patients and nine controls could not be used due
to artefacts discussed in the magnetoencephalography
section below. None of the CT patients or controls pre-
sented with CNS disorders. Eventually, data from 14 CT+
CRT patients, 18 CT patients and 35 controls were used
in the analysis for this paper. Characteristics of these par-
ticipants are reported in Table 1.
The ethical principles of the Helsinki Declaration were
followed and approval was obtained from the Medical
Ethics Committee of the VU University Medical Center
(n° 2006/200). All participants signed an informed con-
sent form.
Magnetoencephalography
MEG was recorded for ten minutes while subjects were
inside a magnetically shielded room (Vacuumschmelze
GmbH, Germany) using a 151 channel whole-head MEG
system (CTF systems Inc., Canada) [19]. A third orderTable 1 Characteristics of the included subjects
CT+CRT CT Controls
(n = 14) (n = 18) (n = 35)
Gender, male % (n) 57.1 (8) 44.4 (8) 45.7 (16)
Age at assessment, y, M (SD) 31.0 (4.3) 24 (2.9) 26.6 (6.1)
Age at diagnosis, y, M (SD) 5.7 (3.4) 4.1 (2.0) N/A
Time since diagnosis, y, M (SD) 25.3 (2.5) 20.0 (2.0) N/A
Estimated IQ, M (SD) 91.9 (18.1) 105.8 (19.9) 108.8 (19.4)
IQ was estimated using a 4-subtest short-form of the Wechsler Adult
Intelligence Scale Revised (WAIS-R III). M mean; SD standard deviation.software gradient was used with a recording passband of
0.25-125 Hz and a sample frequency of 625 Hz in 49
subjects (assessment around 2009), and a sample fre-
quency of 312.5 Hz in 18 subjects (assessment around
2007) [20]. Both sample frequencies occurred in each of
the subject groups. Head position was monitored. MEG
was recorded during a no-task, eyes-closed resting state
condition. For this study, 149 of the 151 channels could
be used. Additionally, 7 channels appeared to produce
no signal for some of the subjects and were appropri-
ately excluded from the calculation of the mean global
and regional powers per subject. MEG recordings were
converted to ASCII files and from these files four arte-
fact free epochs of 13 s per subject were carefully
selected by visual inspection by the two first authors
(based on consensus). The MEG data were filtered in
the following frequency bands: δ (0.5-4 Hz), θ (4–8 Hz),
α1 (8–10 Hz), α2 (10–12 Hz), β (13–30 Hz) and γ (30–
50 Hz). Hypothetically, the lower and upper α bands are
associated with different cognitive processes and many
studies have found differential effects in these subbands
[21,22]. There is no such rationale for subdividing the
other frequency bands. Data in the δ band were largely
corrupted by movement artefacts like breathing. There-
fore, all subjects with artefacts in the δ band were
excluded and group differences were investigated.
Within this artefact-free dataset (CT+CRT n= 10, CT
n= 11, controls n = 12), the groups did not differ on δ
power. Therefore, the δ band was disregarded and more
subjects with artefact-free data in the other frequency
bands were included. Eventually, only 16 subjects (CT+
CRT n= 2, CT n= 5, CON n= 9) were excluded due to
movement artefacts in the other frequency bands, mostly
caused by eye blinks and heart beats.
Relative instead of absolute powers were analyzed, be-
cause absolute powers are partially determined by the
distance between the MEG sensor and the measured
neural substrate. This would result in misleading out-
comes, because part of our population has a smaller
head size due to CRT [23]. The data were processed
using CTF DataEditor and BrainWave 0.8.80 [19,24].
Relative band powers were computed for four 13 s
epochs for each subject in the five frequency bands, and
averaged for each subject. MEG channels were clustered
based upon the approximate underlying cortical areas
(see Figure 1). Regional means were calculated averaging
relative powers of the available channels per cluster, over
four epochs.
Neurocognitive assessment
The Amsterdam Neuropsychological Tasks (ANT) pro-
gram was used to assess EF [25]. The computerized ANT
provides for highly standardized assessments and auto-
mated recordings of speed and accuracy of information
Figure 1 Schematic projection of MEG channels. Head drawing
to illustrate the clustering of channels per region. Midline channels
were disregarded. L = left, R = right, F = frontal, C = central,
P = parietal, O = occipital, T = temporal.
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has proven to be helpful in defining neurocognitive def-
icit profiles in various clinical domains associated with a
generally diffuse impact on the brain, such as phenylke-
tonuria, multiple sclerosis, neurofibromatosis, and mid-
dle late effects of childhood ALL [12,13,26-31]. Based on
these studies, outcome parameters of baseline response
speed, complex visual information processing, sustained
attention, work pace and attentional fluctuations, cogni-
tive flexibility (set shifting and inhibition), visuomotor
skills, and visuospatial sequential working memory were
selected for assessment of this study’s population. Short
task descriptions are given in Table 2, and in more detail
in Additional file 1. The reliability and validity of these
tasks have extensively been described elsewhere [32].
Task parameters that discriminated between the groups
were selected for correlation with MEG data.
Statistical analyses
Individuals’ global and regional means of relative power
were entered in SPSS software (version 16.0; SPSS Inc,
Chicago, IL) for statistical analyses. All powers were
transformed according to the following logarithmic
function [33]:
power ln¼e log power
1 power
 
Global relative power differences between subject
groups were analyzed using a Multivariate General Lin-
ear Model (GLM) with group as between-subjects factor
and the frequency bands as dependent variables. Age
was used as a covariate when significantly correlated
with the dependent variable within the healthy control
group. Wilks’ Lambda corrected F and p-values are
reported. For each frequency band, regional power dif-
ferences between groups were analyzed using a MAN-
OVA for ten regions (bilateral central, frontal, parietal,
occipital and temporal power). Differences between
groups were tested with simple contrasts comparing
each patient group with controls. Partial eta squared (ηp
2)was computed to estimate effect sizes (weak effect: ηp²
 0.03; moderate: ηp² 0.06; large: ηp²≥ 0.14) [34].
Cohen’s d was used for simple contrasts (small effect:
0.2 < d < 0.3; medium: 0.3 < d < 0.8; large: d > 0.8).
Correlations between regional powers and discriminative
cognitive variables
The ANT variables that discriminated between patients
and controls were correlated with MEG regional power
outcomes in the discriminating frequency bands. Pear-
son’s correlations (r) and their p-values were calculated
between regional powers and these neuropsychological
variables, controlling for age. When r in the patient
group or in the control group was significant, the r-
values were compared. First, they were transformed into
z'-values according to the Fisher transformation [35].
The difference |z*| between r1 within the patient group
and r2 within controls was calculated and significance of
that difference was determined by comparing |z*| to
normal z-values [35].
Linear regression models of powers predicting cognitive
performance
Separately for each frequency band, regional means of
relative powers that differed significantly between groups
were entered into linear regression analysis predicting
cognitive parameters that discriminated between groups,
together with age. The backward method was used,
using a probability (F) of 0.05 for entry and 0.10 for
removal.
Results
Global relative power
After elog transformation, separate inspection per group
revealed normal distributions within all frequency bands,
except for α1 in controls (SW statistic: 0.926 (p = 0.022)).
Based on these results, the elog transformation was con-
sidered sufficiently effective to allow for parametric stat-
istical testing.
The groups differed significantly in age (p = 0.001) due
to the consecutive time periods the treatment protocols
were applied. The correlation analyses within the control
group between the powers and age resulted in a signifi-
cant outcome for θ_ln (r =−0.560, p = 0.0005), so age was
used as a covariate in the multivariate power analyses.
The GLM results for the mean global relative powers are
shown in Table 3. In the CT+CRT group, θ power was
slightly increased compared to controls and α2 power
was significantly decreased. Within the CT group, global
power levels did not differ from controls. To facilitate in-
terpretation, Figure 2 displays the untransformed mean
global relative power values per group for all frequency
bands. For additional graphs of transformed and untrans-
formed global relative powers, see Additional file 2.
Table 2 Amsterdam Neuropsychological Tasks program: description of subtests
TASK VARIABLE LABEL
Baseline speed T_bs Baseline speed (simple reaction time)
S_ bs Baseline speed stability
Feature Identification Ts_fi Speed of processing complex visuospatial information (similar condition)
Td_fi Speed of processing simple visuospatial information (dissimilar condition)
diffT_fi Ts_fi minus Td_fi; Extra response time needed for higher order complex visuospatial information processing
Memory Search Objects 2D T1_2d Speed of working memory search processes (low memory load condition); Target detection
T2_2d Speed of working memory search processes (high memory load condition); Requires continuous
monitoring and updating of the contents of the working memory
diffT_2d T2_2d minus T1_2d; Extra response time needed for memory search processes
Sustained attention T_sa Work pace; Response speed on sustained attention
SD_sa Attentional fluctuations; Response speed stability
PM_sa Percentage of misses (errors on target signals)
PF_sa Percentage of false alarms (errors on nontarget signals)
Shifting attentional set T_inhib Speed of inhibition
P_inhib Accuracy of inhibition (% errors)
T_flex Speed of set shifting (flexibility)
P_flex Accuracy of set shifting (flexibility)(% errors)
Tracking Da_tr Visuomotor accuracy; Mean absolute distance to ideal trajectory, mean left and right hand
S_tr Visuomotor stability; mean left and right hand
Dal(r)_tr Visuomotor accuracy; left (right) hand
Pursuit D_pu Visuomotor accuracy; Distance to randomly moving target, mean left and right hand
S_pu Visuomotor stability, mean left and right hand
Dl(r)_pu Visuomotor accuracy; left (right) hand
Sl(r)_pu Visuomotor stability; left (right) hand
Visuospatial sequencing Nit_vs Visuospatial working memory; Number of correctly identified dots in a visuospatial pattern
Nitco_vs Sequential visuospatial working memory; Number of correctly identified dots in correct order
diff_Nit_Nitco Nit_vs minus Nitco_vs; Accuracy of sequential working memory processes
For more elaborate descriptions of these subtests, see Additional file 1.
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For each frequency band, a separate MANOVA was used
to test for regional power differences between groups in
the ten regions shown in Figure 1. The multivariate tests
did not reach significance, with just a trend for theTable 3 Global relative power differences
MANOVA Between-Subjects effects
AGE Sign.
(p)
Effect
size
(ηp
2)
GROUP
Multivariate tests F[5,59] = 2.516 0.039 0.176 F[10,118] = 1.809
θ_ln F[1,63] = 12.404 0.001 0.164 F[2,63] = 2.191
α1_ln F[1,63] = 1.589 0.212 0.025 F[2,63] = 1.057
α2_ln F[1,63] = 4.404 0.040 0.065 F[2,63] = 5.757
β_ln F[1,63] = 1.509 0.224 0.023 F[2,63] = 0.511
γ_ln F[1,63] = 1.810 0.183 0.028 F[2,63] = 1.684
Differences were tested between the CT +CRT group (n = 14), the CT group (n = 18)
* = statistical trend, ** = significant difference.group difference on regional α2 powers (p = 0.067).
Group contrasts versus controls within the θ band
revealed increased powers for the CT+CRT group in
the RC (p = 0.038) and RP (p = 0.029) regions and trends
for increases in the LO (p = 0.066) and RO (p = 0.051)Simple contrasts (versus controls)
Sign.
(p)
Effect
size
(ηp
2)
CT +CRT group CT group
Sign. (p) Cohen’s d Sign. (p) Cohen’s d
0.066* 0.133 N/A N/A N/A N/A
0.120 0.065 0.069* 0.190 0.582 0.061
0.354 0.032 0.152 0.335 0.693 0.201
0.005** 0.155 0.006** −0.719 0.243 0.207
0.602 0.016 0.889 0.171 0.347 −0.371
0.194 0.051 0.117 −0.386 0.218 −0.448
and controls (n = 35) using multivariate GLM, with age as a covariate.
Figure 2 Mean global relative power values. X-axis: Frequency band; y-axis: Mean global relative power (%). Error bars represent one standard
deviation.
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increased levels of α1 power in the LO (p = 0.081) and
RO (p = 0.059) regions. Within the α2 band, the CT+
CRT group displayed decreased power levels in all
regions, except for LF. The CT group only displayed a
significant increase of α2 power (p = 0.030) in the left
frontal region compared to controls. For a table of all
statistics on the multivariate tests and contrasts, see
Additional file 3. Significant contrast results for the CT+
CRT group versus controls are displayed in Figure 3.
The directions of the deviations are colour coded per re-
gion (red for increases, blue for decreases). No signifi-
cant regional Group x Hemisphere interactions were
found.
The time that has passed since treatment could hypo-
thetically allow for either recovery or worsening of late
effects. Therefore, time since diagnosis was correlated
with powers in all frequency bands, separately within
each patient group. There were no significant correla-
tions with either global or regional powers. Hypothetic-
ally, a younger age could mean more vulnerability toα2
Power higher in the CT+CRT group at p < 0.05
Power higher in the CT+CRT group at p < 0.10
Power lower in the CT+CRT group at p <0.05
Power lower in the CT+CRT group at p<0.10
θ
Figure 3 Visualization of regional power differences between
the CT+CRT group and controls. Differences concern the θ and
α2 frequency bands. The directions of the deviations are colour
coded per region (red for increases, blue for decreases).neurotoxicity of treatment. However, no effect of age at
diagnosis was found on either global or regional powers.
Group differences on cognition
The cognitive variables are explained in Additional file 1.
Age did not correlate significantly with any of the cog-
nitive parameters within the control group and was
therefore not used as a covariate. The CT+CRT group
performed worse than controls on measures of cognitive
flexibility (percentage of errors (P_flex, p = 0.002), atten-
tional fluctuations during sustained attention (SD_sa,
p = 0.062), visuomotor accuracy (D_pu, p = 0.049; S_pu,
p = 0.075; Dr_pu, p = 0.015; Sr_pu, p = 0.029) and se-
quential visuospatial working memory (Nit_vs, p = 0.065;
Nitco_vs, p = 0.023; Nit-Nitco_vs, p = 0.036). A table of
statistics, including effect sizes, can be found in Add-
itional file 4. When the CT group was compared with
controls, trends were found for worse sequential visuo-
spatial working memory (Nitco_vs, p = 0.092) and accur-
acy of inhibition (P_inhib, p = 0.059).
Correlations between regional powers and discriminative
cognitive variables
Correlations were calculated within the composite group
of CT+CRT patients and controls to investigate general
patterns. Significantly differentiating regional powers
were correlated with differentiating cognitive variables.
Increased levels of RC and RP θ power correlated signifi-
cantly with worse performance on visuomotor control
(D_pu, Dr_pu and Sr_pu). Decreased α2 powers in the
eight significant regions of the CT+CRT group (LO, LP,
LT, RC, RF, RO, RP and RT) were significantly correlated
with better performance on attentional fluctuations
(SD_sa) and with worse performance on visuomotor
control (D_pu and Dr_pu). Correlations within the CT+
CRT group and within controls were separately calcu-
lated and then compared (see Additional file 5). There
was a trend for the difference between CT+CRT
patients and controls in correlation coefficients of
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This correlation was absent in the CT+CRT group
(r = 0.078), while it was significantly positive in controls
(r = 0.549). Correlations between visuomotor accuracy of
the right hand (Dr_pu) and regional α2 powers differed
significantly in seven regions (not in RF) between CT+
CRT patients (where there were significantly negative
correlations with r ranging from −0.508 to −0.697)), and
controls (where the correlations were not significant and
ranging from −0.129 to 0.142). Roughly the same pattern
was seen in the θ band, but with positive correlations
within the CT+CRT group between Dr_pu and RC θ
(r = 0.630) and RP θ (r = 0.599).
To verify whether the increased LF α2 power level in
the CT group was associated with the mild deficiencies
in accuracy of inhibition and sequential visuospatial
working memory, these outcomes were correlated, but
no significant results were found. The significant corre-
lations between α2 and attentional fluctuations observed
in controls were absent in the CT group.
To explore the possibility that increased levels of θ
power reflect the results of compensatory activity, the
data were searched for associations between increased
regional θ powers and better cognitive performance on
any of the neuropsychological tasks. Two trends were
found for increased left occipital θ power in association
with less attentional fluctuations (r =−0.509, p = 0.075)
and better right hand visuomotor accuracy on the track-
ing task (r =−0.509, p = 0.075). A description of the
tracking task can be found in Additional file 1.
Linear regression models
The differentiating regional powers were entered in lin-
ear regression analysis for each group separately, and for
the composite group of CT+CRT patients and controls.
Of the three pursuit variables, visuomotor accuracy of
the preferred hand (Dr_pu) is best explained by regional
θ power. Within the CT+CRT group, 39.6% variance on
Dr_pu could be explained by increased RC θ power. No
significant model could be reached for controls.
Attentional fluctuations (SD_sa) could be significantly
explained by α2 powers in one or two regions, regardless
of group composition. More variance could be explained
in the CT+CRT group (R2 = 0.653), than in controls
(R2 = 0.345). D_pu and Dr_pu could be significantly
explained by α2 powers in multiple regions. Similarly,
more variance could be explained in CT+CRT patients
(R2 = 0.912 (D_pu) and 0.727 (Dr_pu)) than in controls
(R2 = 0.173 (D_pu) and 0.327 (Dr_pu)). An overview of
linear regression outcomes is given in Additional file 6.
Discussion
The global power spectrum of CRT-treated patients
reflects a slight increase of θ activity and a significantdecrease of α2 activity. Patients treated with CT alone
display a power spectrum similar to controls, except for
a significantly increased level of left frontal α2 power.
Late effects of cranial irradiation
The increase in θ and decrease in α2 indicate a tendency
towards global slowing of brain oscillatory activity, a
finding that is consistent with other recent MEG studies
in low grade glioma patients and Alzheimer patients
[15,16]. Increased θ power is also known as a nonspeci-
fic sign of brain pathology [17]. Our results confirm
Tucker’s findings from 1989 of increased θ and
decreased α power in irradiated patients and are also in
line with results from a review by Klimesch, published in
1999 [18,36]. He concluded that α power is lowered and
θ power enhanced in subjects with a variety of different
neurological disorders. Also in healthy people in the late
part of their lifespan this pattern is familiar and is sup-
posed to reflect some degree of normal aging in the
form of vascular or fibrillary degeneration [17]. Taken
together with the fact that dementia is frequently
reported as a late effect of whole brain irradiation and
the neuropsychological deficiencies currently present,
these findings suggest that the irradiated brain might be
aging faster and could be at risk for early-onset dementia
[18,37-40]. Long-term follow-up of this patient group is
therefore increasingly important. Longitudinal research
is also recommended.
High percentages of variance of visuomotor accuracy,
especially of the right hand, are explained by increased θ
and decreased α2 powers in the CT+CRT group. This is
a strong indication that these deviant power levels are
underlying this particular deficiency. Unexpectedly,
decreased regional α2 powers are significantly associated
with less attentional fluctuations in both irradiated
patients and controls. In general, α is suppressed by
stimuli (e.g. light) and mental activities [17]. Rihs et al.
(2009) describe how α power increases and decreases
co-vary with visual cortex excitability related to anticipa-
tory visual attention processes [41-43]. This illustrates
that patterns of α power fluctuations are difficult to de-
cipher and it is almost impossible to interpolate between
resting state and attentional task data.
The CT+CRT group demonstrates decreased α2 levels
and worse attentional fluctuations. Within the right
frontal region of irradiated patients, where the α2 power
level is decreased, the association with attentional fluc-
tuations is absent, while there is a strong positive associ-
ation in controls. This suggests that especially the
significantly decreased α2 power in the right frontal re-
gion underlies the deficiency in sustained attention in
the CT+CRT group. Lower α2 is not helping sustained
attention here. The α2 associations in the occipital
regions are slightly, although not significantly, stronger
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that the occipital lobes are trying to compensate for
decreased α2 power in the right frontal region.
Additionally, recent research on θ activity, e.g. by
Voytek et al. (2010) [44], suggests that increased θ power
may reflect compensatory activity for a damaged brain
region that is being challenged, rather than reflecting
pathology. In our study, subtle implications were found
for compensatory θ activity in the left occipital lobe.
Combined, the increase in left occipital θ power and
the decrease in occipital α2 powers both being asso-
ciated with less attentional fluctuations, suggest that at-
tentional fluctuations in irradiated patients may be
partly counterbalanced by compensatory activity in the
occipital lobes. One might arguably postulate that the
observed trends for elevated occipital α1 power repre-
sent nothing more than a side effect of working with
relative powers instead of absolute. These slightly
increased levels were not associated with any of the
cognitive deficiencies in the irradiated patients, although
reports have been made about associations between an
increase in lower α power and disturbed working
memory [15].
Late effects of chemotherapy
The patient group treated with CT alone showed no signs
of early aging. The subtlety of the cognitive deficiencies
and limited spectral power changes are consistent with
overall findings that the patients treated with CT only do
not perform significantly worse than controls. The sig-
nificant reduction of late effects makes CT a superior al-
ternative to CRT, especially since there was no trade-off
in terms of mortality or recurrence [1,2]. Event-free sur-
vival at 10 years after treatment with ALL-6 was even
30% better than after treatment with ALL-5 and CNS re-
lapse rates improved from 12.9% to 1.1% [45]. Mean-
while, suspected neurotoxic effects of CT might be
masked by compensatory mechanisms. It remains un-
clear whether the elevated level of left frontal α2 power
should be interpreted as compensatory or pathological. If
lowered α2 is regarded as compensatory, increased α2 in
the CT patients should be regarded as pathological.
However, increased α2 power and the mild cognitive de-
ficiencies observed in the CT patients were not asso-
ciated, which contradicts the pathology hypothesis. In
CT patients, α2 power is not correlated with attentional
fluctuations, so the absence of attentional fluctuations
combined with increased α2 is not necessarily inconsist-
ent with the hypothesis of lower α2 levels being compen-
satory. Also, the possibility of increased α2 being
compensatory in other cognitive domains cannot be
ruled out.
The time that passed since end of treatment (20–
25 years) and the age of the patients at time of treatment(an age of relatively high plasticity of the brain) could
have allowed for alternative brain strategies to develop.
For the CT patients, this could have resulted in mostly
normal cognitive performance. For the irradiated group,
however, neurotoxicity is much more severe. Compensa-
tion might exist, yet appears to be inadequate, which
emphasizes this group’s need for long-term follow-up
and interventions.Methodological considerations
Although there were good reasons for analyzing relative
powers instead of absolute, this also creates a limitation.
A decrease in one frequency band might cause an in-
crease in another band, although this would not be the
observed pattern in absolute measures. On the other
hand, consistency with the literature and significant
associations with cognitive deficiencies support our find-
ings in the CT+CRT group. Another possible limitation
of the study is the relatively small sample size which
raises the question whether this set of subjects is repre-
sentative for the whole population. Confirmation by fu-
ture studies is needed.
No corrections were applied for multiple compari-
sons, although commonly the Bonferroni method would
be applied in order to lower the chances of false discov-
ery of significant results (the type I error rate). In a
publication by Perneger et al. (1998), a view widely held
by epidemiologists is expressed that this method creates
more problems than it solves and the best way of deal-
ing with multiple comparisons is by simply describing
what tests of significance have been performed, and
why [46]. This way, findings are not interpreted differ-
ently according to how many other tests were per-
formed. Also, type I errors cannot be prevented without
increasing the number of type II errors, which are
equally worth avoiding. In the present study, pre-
established hypotheses were tested in our correlation
analyses, instead of just correlating everything, and more
than 50% of these hypotheses were confirmed. In
addition, the correlation results were supported by the
regression results. This, combined with reporting effect
sizes in addition to significance levels, should provide
the reader with sufficient information to base an inter-
pretation of the results on.Conclusions
Power spectrum analysis of MEG registrations is able to
demonstrate abnormal patterns of resting-state oscilla-
tory brain activity in irradiated long-term survivors of
ALL. The suspicion of a faster aging brain after CRT
warrants careful long-term follow-up and screening for
early-onset dementia. In future ALL therapy, CRT
should be completely abolished.
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